The grants to four scientists at Columbia University Vagelos College of Physicians and Surgeons support unconventional approaches to major challenges in biomedical and behavioral research.
Physician-scientist Juanma Schvartzman is a firm believer that his curiosity-driven research on cell metabolism and its influence on cell identity will offer clues for better cancer treatments.
A new study finds that many of our genes, if disabled by a mutation, have a surprising ability to turn on backup genes to compensate for lost functions.
Columbia's Maja Bergman discuss the types of challenges domestic violence survivors face, effective therapies for those who experience domestic abuse, and warning signs that someone may be an abuser.
Columbia neuroscientists have identified a genetic mutation that fends off Alzheimer's in people at high risk and could lead to a new way to protect people from the disease.
Study finds that postpartum depression is underdiagnosed in those reporting symptoms up to a year after giving birth, with Black and Asian individuals least likely to receive treatment.
With funding from the Ultra-rare Gene-based Therapy Network, scientists at Columbia and the n-Lorem Foundation will create tailor-made gene-based therapies for people with rare forms of ALS.
Far-UVC light dramatically reduced airborne virus levels in a room where people were working, in the first study of the new air disinfection technology outside of an experimental setting.
Columbia biomedical engineers are collaborating with orthopedic surgeons to build a living replacement knee to be tested in clinical trials within five years.
Columbia genome engineers are designing a CRISPR-based gene therapy with potential to prevent blindness in anyone with retinitis pigmentosa, a condition caused by more than 80 different genes.